The DOI matches its Crossref record; 416 of the 416 references it cites were found in a registry or an index.
The Prostanoid EP4 Receptor and Its Signaling Pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells
Subbaramaiah, K., Hudis, C. A., Chang, S.-H., Hla, T., & Dannenberg, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705409200 · Cited by 89
RetractedSingh, T., & Katiyar, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025224 · Cited by 83
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
A Protein Binding Assay for Adenosine 3′:5′-Cyclic Monophosphate
Gilman, A. G. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.67.1.305 · Cited by 3,249
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,969
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
CD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,798
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Boolell, M., Mj, A., Sa, B., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Ih, O., & Gingell, C. (1996) · PubMed · Cited by 1,067
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Seder, R. A., Gazzinelli, R., Sher, A., & Paul, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10188 · Cited by 976
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
G protein-coupled receptors: novel targets for drug discovery in cancer
Lappano, R., & Maggiolini, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3320 · Cited by 717
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
ADENYL CYCLASE AS AN ADRENERGIC RECEPTOR*
Robison, G. A., Butcher, R. W., & Sutherland, E. W. (1967) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1967.tb41239.x · Cited by 673
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J., & Aarden, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.775 · Cited by 666
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Morphology, physiology, and molecular biology of renin secretion
Hackenthal, E., Paul, M., Ganten, D., & Taugner, R. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1067 · Cited by 614
Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y., & Narumiya, S. (2009) · Nature Medicine · doi:10.1038/nm.1968 · Cited by 566
Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030058 · Cited by 560
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase
Trebino, C. E., Stock, J. L., Gibbons, C. P., Naiman, B. M., Wachtmann, T. S., Umland, J. P., Pandher, K., Lapointe, J.-M., Saha, S., Roach, M. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332766100 · Cited by 552
Biosynthesis of Prostaglandins
Lands, W. E. M. (1991) · Annual Review of Nutrition · doi:10.1146/annurev.nu.11.070191.000353 · Cited by 507
Scandella, E., Men, Y., Gillessen, S., Förster, R., & Groettrup, M. (2002) · Blood · doi:10.1182/blood-2001-11-0017 · Cited by 500
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Savarese, T. M., & Fraser, C. M. (1992) · Biochemical Journal · doi:10.1042/bj2830001 · Cited by 473
Epac: Defining a New Mechanism for cAMP Action
Gloerich, M., & Bos, J. L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105714 · Cited by 473
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53022-2 · Cited by 472
Hizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 465
Organization and Ca2+Regulation of Adenylyl Cyclases in cAMP Microdomains
Willoughby, D., & Cooper, D. M. F. (2007) · Physiological Reviews · doi:10.1152/physrev.00049.2006 · Cited by 451
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
Manetti, R., Gerosa, F., Giudizi, M. G., Biagiotti, R., Parronchi, P., Piccinni, M. P., Sampognaro, S., Maggi, E., Romagnani, S., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1273 · Cited by 436
G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
Gurevich, E. V., Tesmer, J. J. G., Mushegian, A., & Gurevich, V. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.08.001 · Cited by 423
EP2 and EP4 prostanoid receptor signaling
Regan, J. W. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.031 · Cited by 420
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Suzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Endocrinology · doi:10.1210/en.141.4.1554 · Cited by 415
von Euler, U. S. (1934) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01861161 · Cited by 405
The biosynthesis of prostaglandins
Van Dorp, D. A., Beerthuis, R. K., Nugteren, D. H., & Vonkeman, H. (1964) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(64)90144-8 · Cited by 392
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391
Conti, M. A., & Adelstein, R. S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69586-4 · Cited by 390
Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., Fairbairn, C. E., Kedzie, K. M., Woodward, D. F., & Gil, D. W. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09674-9 · Cited by 390
Molecular mechanisms of diverse actions of prostanoid receptors
Negishi, M., Sugimoto, Y., & Ichikawa, A. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00146-4 · Cited by 387
Harizi, H., Juzan, M., Pitard, V., Moreau, J.-F., & Gualde, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2255 · Cited by 384
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists
Severn, A., Rapson, N. T., Hunter, C. A., & Liew, F. Y. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3441 · Cited by 383
Compartmentation of G Protein-Coupled Signaling Pathways in Cardiac Myocytes
Steinberg, S. F., & Brunton, L. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.751 · Cited by 383
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.
Watabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negishi, M., Ito, S., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80710-8 · Cited by 372
G protein βγ subunits: Central mediators of G protein-coupled receptor signaling
Smrcka, A. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8006-5 · Cited by 365
Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4333 · Cited by 363
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., & Maraskovsky, E. (2002) · Blood · doi:10.1182/blood-2001-12-0360 · Cited by 358
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.
Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., & Narumiya, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50448-3 · Cited by 357
Effects of Prostaglandins on Adenosine 3′,5′-Monophosphate Levels in Fat and Other Tissues
Butcher, R. W., & BAIRD, C. E. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93504-0 · Cited by 354
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15528 · Cited by 352
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., Yamaguchi, K., Segi, E., Tsuboyama, T., Matsushita, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062053399 · Cited by 345
AKAP Mediated Signal Transduction
Michel, J. J. C., & Scott, J. D. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.083101.135801 · Cited by 342
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S. K., & DuBois, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052124 · Cited by 338
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
Takayama, K., Garcı́a-Cardeña, G., Sukhova, G. K., Comander, J., Gimbrone, M. A., & Libby, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204810200 · Cited by 337
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18910 · Cited by 336
Cyclooxygenase-2 and prostaglandins in articular tissues
Martel-Pelletier, J., Pelletier, J.-P., & Fahmi, H. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(03)00134-3 · Cited by 333
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215528 · Cited by 320
Kabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., & Narumiya, S. (2003) · Nature Medicine · doi:10.1038/nm872 · Cited by 316
Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 313
Prostaglandins in bone: bad cop, good cop?
Blackwell, K. A., Raisz, L. G., & Pilbeam, C. C. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.004 · Cited by 311
Fujino, H., West, K. A., & Regan, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109440200 · Cited by 310
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
Funk, C. D., Furci, L., FitzGerald, G. A., Grygorczyk, R., Rochette, C., Bayne, M. A., Abramovitz, M., Adam, M., & Metters, K. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74379-8 · Cited by 310
Fujino, H., Xu, W., & Regan, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212665200 · Cited by 305
Studies of the characterisation of prostanoid receptors: A proposed classification
Kennedy, I., Coleman, R. A., Humphrey, P. P. A., et al. (1982) · Prostaglandins · doi:10.1016/0090-6980(82)90036-3 · Cited by 305
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
Boie, Y., Stocco, R., Sawyer, N., Slipetz, D. M., Ungrin, M. D., Neuschäfer-Rube, F., Püschel, G. P., Metters, K. M., & Abramovitz, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01383-6 · Cited by 296
Biochemical Studies of Human Semen. II. The Action of Semen on the Human Uterus.
Kurzrok, R., & Lieb, C. C. (1930) · Experimental Biology and Medicine · doi:10.3181/00379727-28-5265 · Cited by 288
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R. B., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13640 · Cited by 287
Mazzucchelli, L., Hauser, C. J., Z’graggen, K., Wagner, H., Hess, M. W., Laissue, J. A., & Mueller, C. (1994) · PubMed Central · Cited by 286
Sheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8138 · Cited by 284
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh-ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400199200 · Cited by 279
Self-citationCyclooxygenase 2 is a key enzyme for inflammatory cytokine‐induced angiogenesis
Kuwano, T., Nakao, S., Yamamoto, H., Tsuneyoshi, M., Yamamoto, T., Kuwano, M., & Ono, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0473com · Cited by 279
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113640 · Cited by 278
A novel inhibitory prostanoid receptor in piglet saphenous vein
Coleman, R. A., Grix, S. P., Head, S. A., Louttit, J. B., Mallett, A., & Sheldrick, R. L. G. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90084-1 · Cited by 273
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510562103 · Cited by 267
Dohadwala, M., Batra, R. K., Luo, J., Lin, Y., Krysan, K., Põld, M., Sharma, S., & Dubinett, S. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210707200 · Cited by 260
Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity
Lin, C.-R., Amaya, F., Barrett, L., Wang, H., Takada, J., Samad, T. A., & Woolf, C. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105569 · Cited by 257
Ostrom, R. S., Gregorian, C., Drenan, R. M., Xiang, Y., Regan, J. W., & Insel, P. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105348200 · Cited by 250
Mechanisms Regulating the Ductus Arteriosus
Clyman, R. I. (2006) · Neonatology · doi:10.1159/000092870 · Cited by 250
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
Bastien, L., Sawyer, N., Grygorczyk, R., Metters, K. M., & Adam, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32654-6 · Cited by 246
Aronoff, D. M., Canetti, C., Serezani, C. H., Luo, M., & Peters-Golden, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.595 · Cited by 241
Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease
Nielsen, O. H., Kirman, I., Rüdiger, N., Hendel, J., & Vainer, B. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000672 · Cited by 240
Nagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J. K., Grazette, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23073 · Cited by 230
G Protein–Coupled Prostanoid Receptors and the Kidney
Breyer, M. D., & Breyer, R. M. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.579 · Cited by 226
Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., & Narumiya, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11192 · Cited by 225
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J., & Maraskovsky, E. (2005) · Blood · doi:10.1182/blood-2004-05-1718 · Cited by 218
Regulation by Ca2+-Signaling Pathways of Adenylyl Cyclases
Halls, M. L., & Cooper, D. M. F. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004143 · Cited by 217
Attur, M., Al-Mussawir, H. E., Patel, J., Kitay, A., Dave, M., Palmer, G., Pillinger, M. H., & Abramson, S. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5082 · Cited by 216
Zhang, J., & Rivest, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00682.x · Cited by 216
In vitro characterization of prostanoid receptors on human myometrium at term pregnancy
Senior, J., Marshall, K., Sangha, R., & Clayton, J. K. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12832.x · Cited by 214
Sugimoto, Y., Negishi, M., Hayashi, Y., Namba, T., Honda, A., Watabe, A., Hirata, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53832-1 · Cited by 212
The Pharmacology of the Ductus Arteriosus
Smith, G. C. S. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01348-6 · Cited by 212
Katsushika, S., Chen, L., Kawabe, J., Nilakantan, R., Halnon, N. J., Homcy, C. J., & Ishikawa, Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8774 · Cited by 209
Self-citationImpaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice
Miyaura, C., Inada, M., Suzawa, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002079200 · Cited by 208
Honda, T., Segi-Nishida, E., Miyachi, Y., & Narumiya, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051310 · Cited by 208
Epac Mediates β-Adrenergic Receptor–Induced Cardiomyocyte Hypertrophy
Métrich, M., Lucas, A., Gastineau, M., Samuel, J.-L., Heymes, C., Morel, E., & Lezoualc’h, F. (2008) · Circulation Research · doi:10.1161/circresaha.107.164947 · Cited by 207
Legler, D. F., Krause, P., Scandella, E., Singer, E., & Groettrup, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.966 · Cited by 203
Kitase, Y., Barragan, L., Qing, H., Kondoh, S., Jiang, J. X., Johnson, M. L., & Bonewald, L. F. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.168 · Cited by 202
Togo, S., Holz, O., Liu, X., Sugiura, H., Kamio, K., Wang, X., Kawasaki, S., Ahn, Y., Fredriksson, K., Skold, C. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-929oc · Cited by 202
Faour, W. H., He, Y., He, Q. W., de Ladurantaye, M., Quintero, M., Mancini, A., & Di Battista, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104036200 · Cited by 197
Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle
Morgado, M., Cairrão, E., Santos-Silva, A. J., & Verde, I. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0815-2 · Cited by 196
Regulation of Macrophage Cytokine Production by Prostaglandin E2
Williams, J. A., & Shacter, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25693 · Cited by 191
cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy
Morel, E., Marcantoni, A., Gastineau, M., Birkedal, R., Rochais, F., Garnier, A., Lompré, A.-M., Vandecasteele, G., & Lezoualc’h, F. (2005) · Circulation Research · doi:10.1161/01.res.0000194325.31359.86 · Cited by 189
Suppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105
Wall, E. A., Zavzavadjian, J. R., Chang, M. S., Randhawa, B., Zhu, X., Hsueh, R. C., Liu, J., Driver, A., Bao, X. R., Sternweis, P. C., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000202 · Cited by 188
Southall, M. D., & Vasko, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011408200 · Cited by 182
Schnizler, K., Shutov, L. P., Van Kanegan, M. J., Merrill, M. A., Nichols, B., McKnight, G. S., Strack, S., Hell, J. W., & Usachev, Y. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0233-08.2008 · Cited by 181
Walton, L. J., Franklin, I. J., Bayston, T., Brown, L. C., Greenhalgh, R. M., Taylor, G. W., & Powell, J. T. (1999) · Circulation · doi:10.1161/01.cir.100.1.48 · Cited by 181
Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
Jain, S., Chakraborty, G., Raja, R., Kale, S., & Kundu, G. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6689 · Cited by 177
Huang, S., Wettlaufer, S. H., Hogaboam, C., Aronoff, D. M., & Peters-Golden, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00232.2006 · Cited by 175
Nishikawa, M., de Lanerolle, P., Lincoln, T. M., & Adelstein, R. S. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39749-1 · Cited by 174
Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2
Machwate, M., Harada, S., Leu, C. T., Seedor, G., Labelle, M., Gallant, M., Hutchins, S., Lachance, N., Sawyer, N., Slipetz, D., et al. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23047-9 · Cited by 172
Use of Aspirin postdiagnosis improves survival for colon cancer patients
Bastiaannet, E., Sampieri, K., Dekkers, O. M., de Craen, A. J. M., van Herk-Sukel, M. P. P., Lemmens, V, van den Broek, C. B. M., Coebergh, J. W., Herings, R. M. C., van de Velde, C. J. H., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.101 · Cited by 171
Sales, K. J., Katz, A. A., Howard, B., Soeters, R., Millar, R. P., Jabbour, H. N., & Soeters, R. P. (2002) · PubMed · Cited by 170
Yokoyama, U., Minamisawa, S., Quan, H., Ghatak, S., Akaike, T., Segi-Nishida, E., Iwasaki, S., Iwamoto, M., Misra, S., Tamura, K., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28639 · Cited by 169
Self-citationApoptosis of Cardiac Myocytes in Gsα Transgenic Mice
Geng, Y.-J., Ishikawa, Y., Vatner, D. E., Wagner, T. E., Bishop, S. P., Vatner, S. F., & Homcy, C. J. (1999) · Circulation Research · doi:10.1161/01.res.84.1.34 · Cited by 165
Self-citationProstaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis
Ma, X., Kundu, N., Rifat, S., Walser, T., & Fulton, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4348 · Cited by 160
Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation
Pozzi, A., Yan, X. S., Macias‐Perez, I., Wei, S. D., Hata, A. N., BREYER, R. M., Morrow, J. D., & Capdevila, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313989200 · Cited by 160
Prostaglandin E 2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP 4
Xiao, C.-Y., Yuhki, K.-I., Hara, A., Fujino, T., Kuriyama, S., Yamada, T., Takayama, K., Takahata, O., Karibe, H., Taniguchi, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128046.54681.97 · Cited by 160
Tanaka, A., Hase, S., Miyazawa, T., & Takeuchi, K. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.754 · Cited by 159
A review — Role of eicosanoids in vertebrate ovulation
Murdoch, W. J., Hansen, T. R., & McPherson, L. A. (1993) · Prostaglandins · doi:10.1016/0090-6980(93)90037-8 · Cited by 158
The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and Northern blot analysis
Katsuyama, M., Nishigaki, N., Sugimoto, Y., Morimoto, K., Negishi, M., Narumiya, S., & Ichikawa, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00966-d · Cited by 156
Sales, K. J., Katz, A. A., Davis, M., Hinz, S., Soeters, R., Hofmeyr, M. D., Millar, R. P., & Jabbour, H. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7442 · Cited by 155
Napolitani, G., Rodríguez, E. V. A., Lanzavecchia, A., & Sallusto, F. (2009) · European Journal of Immunology · doi:10.1002/eji.200838969 · Cited by 155
Cytosolic Phospholipase A2α–deficient Mice Are Resistant to Collagen-induced Arthritis
Hegen, M., Sun, L., Uozumi, N., Kume, K., Goad, M. E. P., Nickerson‐Nutter, C. L., Shimizu, T., & Clark, J. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030016 · Cited by 155
Tang, T.-S., Tu, H., Wang, Z., & Борисович, Б. И. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00403.2003 · Cited by 155
Sheibanie, A. F., Khayrullina, T., Safadi, F. F., & Ganea, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22794 · Cited by 151
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Kim, J. I., Lakshmikanthan, V., Frilot, N., & Daaka, Y. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0511 · Cited by 151
Oka, T., Oka, K., Scammell, T. E., Lee, C., Kelly, J. F., Nantel, F., Elmquist, J. K., & Saper, C. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001204)428:1<20::aid-cne3>3.0.co;2-x · Cited by 150
Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation
Hoshino, T., Tsutsumi, S., Tomisato, W., Hwang, H.-J., Tsuchiya, T., & Mizushima, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212097200 · Cited by 149
Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2
An, S. Z., Yang, J., Xia, M., & Goetzl, E. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2470 · Cited by 146
Thomason, P. A., James, S., Casey, P. J., & Downes, C. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89418-8 · Cited by 145
Calabresi, L., Rossoni, G., Gomaraschi, M., Sisto, F., Berti, F., & Franceschini, G. (2003) · Circulation Research · doi:10.1161/01.res.0000054201.60308.1a · Cited by 145
Molecular evolution of receptors for eicosanoids
Toh, H., Ichikawa, A., & Narumiya, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00129-w · Cited by 143
Ha, C. H., Kim, J., Zhao, J., Wang, W., Jhun, B. S., Wong, C. N., & Jin, Z. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000462107 · Cited by 142
Wang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2008) · Circulation · doi:10.1161/circulationaha.107.731398 · Cited by 142
Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2
Tajima, T., Murata, T., Aritake, K., Urade, Y., Hirai, H., Nakamura, M., Ozaki, H., & Hori, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137992 · Cited by 142
Chell, S. D., Witherden, I. R., Dobson, R. R., Moorghen, M., Herman, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3702 · Cited by 141
Nishihara, H., Kizaka‐Kondoh, S., Insel, P. A., & Eckmann, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533221100 · Cited by 140
Inoue, H., Takamori, M., Shimoyama, Y., Ishibashi, H., Yamamoto, S., & Koshihara, Y. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704705 · Cited by 139
Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype
Nishigaki, N., Negishi, M., Honda, A., Sugimoto, Y., Namba, T., Narumiya, S., & Ichikawa, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00421-5 · Cited by 139
King, V. L., Trivedi, D. B., Gitlin, J. M., & Loftin, C. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000216119.79008.ac · Cited by 137
Song, X., Wang, Z.-B., Gan, Q., & Walters, E. T. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00503.2005 · Cited by 135
Prabhakar, U., Lipshutz, D. B., Bartus, J. O., Slivjak, M. J., Smith, E. F., Lee, J. C., & Esser, K. M. (1994) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)90054-x · Cited by 135
Rao, R., Redha, R., Macias‐Perez, I., Yan, S., Hao, C., Zent, R., Breyer, M. D., & Pozzi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701214200 · Cited by 133
Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
Sugimoto, Y., Namba, T., Shigemoto, R., Negishi, M., Ichikawa, A., & Narumiya, S. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.5.f823 · Cited by 133
Xin, X., Majumder, M., Girish, G. V., Mohindra, V., Maruyama, T., & Lala, P. K. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.90 · Cited by 132
Steenport, M. L., Khan, K. M. F., Du, B., Barnhard, S. E., Dannenberg, A. J., & Falcone, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901925 · Cited by 132
Kuroda, E., & Yamashita, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.757 · Cited by 130
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway
Zhang, Y., & Daaka, Y. (2011) · Blood · doi:10.1182/blood-2011-04-350587 · Cited by 130
Seldon, P. M., Barnes, P. J., Meja, K. K., & Giembycz, M. A. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10530-0 · Cited by 129
Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats
Takeuchi, K., Yagi, K., Kato, S., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352857 · Cited by 129
Prostaglandin E2, an Immunoactivator
Sakata, D., Yao, C., & Narumiya, S. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r03cp · Cited by 128
EP4 Prostanoid Receptor Coupling to a Pertussis Toxin-Sensitive Inhibitory G Protein
Fujino, H., & Regan, J. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017749 · Cited by 127
Olesen, E. T. B., Rützler, M. R., Moeller, H. B., Prætorius, H. A., & Fenton, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104691108 · Cited by 126
Okumura, S., Kawabe, J.-I., Yatani, A., Takagi, G., Lee, M.-C., Hong, C., Liu, J., Takagi, I., Sadoshima, J., Vatner, D. E., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000086986.35568.63 · Cited by 126
Self-citationProstaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Huang, S. K., Wettlaufer, S. H., Chung, J., & Peters-Golden, M. L. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0080oc · Cited by 126
Wu, M., Shoji, Y., Wu, M., Chuang, P., Lin, C.-C., Huang, M., & Tsai, S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61195-9 · Cited by 123
Nakao, K., Murase, A., Ohshiro, H., Okumura, T., Taniguchi, K., Murata, Y., Masuda, M., Kato, T., Okumura, Y., & Takada, J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122010 · Cited by 122
Banu, S. K., Lee, J., Speights, V. O., Starzinski‐Powitz, A., & Arosh, J. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0017 · Cited by 122
EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries
Davis, R. J., Murdoch, C. E., Ali, M., Purbrick, S., Ravid, R., Baxter, G. S., Tilford, N., Sheldrick, R. L. G., Clark, K. L., & Coleman, R. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705645 · Cited by 121
Sakuma, Y., Tanaka, K., Suda, M., Yasoda, A., Natsui, K., Tanaka, I., Ushikubi, F., Narumiya, S., Segi‐Nishida, E., Sugimoto, Y., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.218 · Cited by 121
Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi‐Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 120
Prostaglandin E receptor subtypes in mouse osteoblastic cell line
Suda, M., Tanaka, K., Natsui, K., Usui, T., Tanaka, I., Fukushima, M., Shigeno, C., Konishi, J., Narumiya, S., Ichikawa, A., et al. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612504 · Cited by 118
Yang, L., Huang, Y., Porta, R., Yanagisawa, K., González, A., Segi‐Nishida, E., Johnson, D. H., Narumiya, S., & Carbone, D. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1271 · Cited by 117
Hakeda, Y., Yoshino, T., Natakani, Y., Kurihara, N., Maeda, N., & Kumegawa, M. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280204 · Cited by 116
Type-specific Regulation of Adenylyl Cyclase
Onda, T., Hashimoto, Y., Nagai, M., KURAMOCHI, H., Saito, S., Yamazaki, H., Toya, Y., Sakai, I., Homcy, C. J., Nishikawa, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107233200 · Cited by 115
Self-citationIkegami, R., Sugimoto, Y., Segi‐Nishida, E., Katsuyama, M., Karahashi, H., Amano, F., Maruyama, T., Yamane, H., Tsuchiya, S., & Ichikawa, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4689 · Cited by 115
Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
Babaev, V. R., Chew, J. D., Ding, L., Davis, S., Breyer, M. D., BREYER, R. M., Oates, J. A., Fazio, S., & Linton, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.005 · Cited by 114
Hikiji, H., Takato, T., Shimizu, T., & Ishii, S. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.003 · Cited by 114
Sanada, S., Kitakaze, M., Papst, P. J., Asanuma, H., Node, K., Takashima, S., Asakura, M., Ogita, H., Liao, Y., Sakata, Y., et al. (2001) · Circulation · doi:10.1161/hc3201.092216 · Cited by 113
Zieba, B. J., Artamonov, M. V., Jin, L., Momotani, K., Ho, R., Franke, A. S., Neppl, R. L., Stevenson, A. S., Khromov, A. S., Chrzanowska‐Wodnicka, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.205062 · Cited by 112
Pan, M., Hou, M., Chang, H., & Hung, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710038200 · Cited by 112
EP4 receptor as a new target for bronchodilator therapy
Buckley, J., Birrell, M. A., Maher, S. A., Nials, A. T., Clarke, D. L., & Belvisi, M. (2011) · Thorax · doi:10.1136/thx.2010.158568 · Cited by 112
Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands
Leduc, M., Breton, B., Galès, C., Gouill, C. L., Bouvier, M., Chemtob, S., & Heveker, N. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156398 · Cited by 111
Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2
Flanagan, A. M., & Chambers, T. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1309342 · Cited by 108
Some Biological Effects of Two Crystalline Prostaglandin Factors
Bergström, S., ELIASSON, R., von Euler, U. S., et al. (1959) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1959.tb01685.x · Cited by 108
Akaogi, J., Nozaki, T., Satoh, M., & Yamada, H. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006779025711 · Cited by 108
Cited by
Arachidonic Acid Metabolism and Kidney Inflammation
Wang, T., Fu, X., Chen, Q., Patra, J. K., Wang, D., Wang, Z., & Gai, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153683 · Cited by 430
Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz021 · Cited by 263
Convergence of Sex Differences and the Neuroimmune System in Autism Spectrum Disorder
McCarthy, M. M., & Wright, C. L. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.004 · Cited by 158
Dalvi, S., Nguyen, H. H., On, N., Mitchell, R. W., Aukema, H. M., Miller, D. W., & Hatch, G. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13117 · Cited by 37
Metadata
- Authors
- Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T., & Ishikawa, Y.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 65
- Issue
- 3
- Pages
- 1010-1052
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2152588224
- Cited by
- 264
- References
- 416
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.